Osteoarthritis in the Knee is the Most Common Form of Arthritis, and Studies Show it Can be Combated Using Regenerative Techniques Global Institute of Stem Cell Therapy and Research (GIOSTAR), a world leader in stem cell research, was one of the first institutions in the […]
Arthritis impacts more than a quarter of adults in the United States. Learn more about your options for managing this disorder in this post.
Companies pursuing many treatments with a promising Type 2 Diabetes treatment topping the list SAN DIEGO, CA, USA, September 10, 2021 /EINPresswire.com/ — GIOSTAR, the Global Institute of Stem Cell Therapy and Research, has teamed with Cellebration Life Sciences, Inc. to provide world-class research and […]
Quantum Healing as an Alternative Healing Method in Chicago, IL Quantum healing considers the comprehensive treatment of your mind and body, as opposed to simply treating your symptoms on a superficial level. This holistic alternative healing method centers on utilizing the network of intelligence inside […]
GIOSTAR Chicago | Posted on Sep 24, 2021 Research on Stem Cell Benefits for Alopecia Was Published by GIOSTAR Co-Founder Mesenchymal Stem Cell-derived Conditioned Media induces hair growth and improves the severity of Alopecia from 6% to almost 0%, according to the study by GIOSTAR Chicago CSO. GIOSTAR […]
GIOSTAR Chicago | Posted on Sep 24, 2021 GIOSTAR Chicago introduces stem cell therapy with platelet rich plasma therapy to combat the issue of hair thinning. The procedure restores proper blood circulation and growth factors to the hair follicles. GIOSTAR Chicago, an Illinois-based regenerative technologies clinic, is introducing […]
GIOSTAR CEO and Co-Founder Deven Patel spoke on the most downloaded episode of the “Exploring Leadership” podcast, hosted by military veteran Spence Taylor
GIOSTAR has continuously set the bar for innovation in cancer research. The firm was recently recognized with a prestigious award, given to only 9 other researchers.
Looking to educate yourself about Fluid Flow Treatment? The amniotic fluid allograft being offered by GIOSTAR is just the latest example of our commitment to innovation in healthcare.
IMPORTANT! All information presented in this website is intended for informational purposes only and not for the purpose of rendering medical advice. Statements made on this website have not been evaluated by the Food and Drug Administration. The information contained herein is not intended to diagnose, treat, cure or prevent any disease.
